Mira Pharmaceuticals (MIRA) Receivables - Other (2023 - 2025)
Mira Pharmaceuticals' (MIRA) quarterly Receivables - Other came in at $35439.0 in Q4 2025, little changed year-on-year from $35439.0 in Q4 2024, and little changed quarter-over-quarter from $35439.0 in Q3 2025.
Mira Pharmaceuticals (MIRA) Receivables - Other (2023 - 2025) Analysis & Trends
Mira Pharmaceuticals has disclosed Receivables - Other across 3 years of filings, most recently posting $35439.0 for Q4 2025.
- Receivables - Other for Q4 2025 came in at $35439.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $35439.0 (changed 0.0% YoY), and the FY2025 annual result was $35439.0, changed 0.0% from the prior year.
- Receivables - Other came in at $35439.0 for Q4 2025 at Mira Pharmaceuticals, roughly flat from $35439.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $93487.0 in Q1 2024 to a low of $11862.0 in Q4 2023.
- The 3-year median for Receivables - Other is $35439.0 (2024), against an average of $45559.8.
- Across the five-year window, Receivables - Other jumped 198.76% in 2024 and slumped 62.09% in 2025, its largest moves.
- Mira Pharmaceuticals' Receivables - Other stood at $11862.0 in 2023, then surged by 198.76% to $35439.0 in 2024, then changed by 0.0% to $35439.0 in 2025.
- The last three Receivables - Other figures came in at $35439.0 (Q4 2025), $35439.0 (Q3 2025), and $35439.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Mira Pharmaceuticals | 23.69 Mn | 12.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35,439.00 |
| Dec 31, 2025 | 35,439.00 |
| Sep 30, 2025 | 35,439.00 |
| Sep 30, 2025 | 35,439.00 |
| Jun 30, 2025 | 35,439.00 |
| Jun 30, 2025 | 35,439.00 |
| Mar 31, 2025 | 35,439.00 |
| Mar 31, 2025 | 35,439.00 |
| Dec 31, 2024 | 35,439.00 |
| Dec 31, 2024 | 35,439.00 |
| Sep 30, 2024 | 35,439.00 |
| Sep 30, 2024 | 35,439.00 |
| Jun 30, 2024 | 83,175.00 |
| Jun 30, 2024 | 83,175.00 |
| Mar 31, 2024 | 93,487.00 |
| Mar 31, 2024 | 93,487.00 |
| Dec 31, 2023 | 11,862.00 |
| Dec 31, 2023 | 11,862.00 |
| Sep 30, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |